BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 38387896)

  • 1. [Study on the Effect and Mechanism of Tetrandrine on Bone Marrow Mesenchymal Stem Cell-Mediated Drug Resistance in Leukemia].
    Zhou XY; Jin N; Chen BA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):33-38. PubMed ID: 38387896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tetrandrine overcomes drug resistance mediated by bone marrow microenvironment by regulating the expression of P-glycoprotein in acute leukemia.
    Zhou X; Jin N; Chen B
    Hematology; 2022 Dec; 27(1):274-279. PubMed ID: 35192780
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inducing apoptosis and reversal effect of nilotinib in combination with tetrandrine on multidrug resistance of K562/A02 cell line].
    Cui TY; Chen BA; Ding JH; Gao C; Cheng J; Bao W; Zhong YJ; Shan XY; Gao F; Xia GH; Schmitt A; Schmitt M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):28-33. PubMed ID: 21362216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of tetrandrine combined with daunorubicin on expressions of P21 and P-gp in K562/A02 cells].
    Chen BA; Li J; Chen J; Gao F; Wu YN; Zhu MS; Ding JH; Gao C; Sun XC; Xu WL; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1179-82. PubMed ID: 19840446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of tetrandrine and 5-bromotetrandrine in reversing multidrug resistance may relate to down-regulation of multidrug resistance associated protein 7 expression.
    Cheng J; Dai JY; Chen BA; Cai XH; Wang S; Gao F
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):558-63. PubMed ID: 22739155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomolecular mechanisms of cyclosporine A, tetrandrine and their combination on the reversion of multidrug resistance in human leukemia cell line].
    Chen BA; Guo JJ; Cheng J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Nov; 28(11):1010-3. PubMed ID: 19213345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal effect of PI3-K inhibitor LY294002 on P-glycoprotein-mediated multidrug resistance of human leukemia cell line K562/DNR and gastric cancer cell line SGC7901/ADR.
    Zhang Y; Qu XJ; Liu YP; Yang XH; Hou KZ; Teng YE; Zhang JD
    Ai Zheng; 2009 Feb; 28(2):97-9. PubMed ID: 19550116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptotic mechanism of human leukemia K562/A02 cells induced by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
    Wang J; Chen B; Cheng J; Cai X; Xia G; Liu R; Wang X
    Int J Nanomedicine; 2011; 6():1027-34. PubMed ID: 21720514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of D, L-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol and tetrandrine on the reversion of multidrug resistance in K562/A02 cells.
    Chen B; Yin L; Cheng J; Ding J; Gao C; Sun Y; Zhao G; Wang J; Bao W; Xia G; Gao F; Wang X
    Hematology; 2011 Jan; 16(1):24-30. PubMed ID: 21269564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of 5-bromotetrandrine and daunorubicin on apoptosis and expression of survivin in K562/A02 cells].
    Cai XH; Chen BA; Cheng J; Wang J; Ding JH; Bao W; Zhong YJ; Gao F; Xu WL; Shen HL; Wei HL; Chen J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):24-7. PubMed ID: 21362215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of tetrandrine and droloxifene on the reversion of drug resistance of K562/A02 cell line and induction of apoptosis].
    Chen B; Dong Y; Zhang P; Cheng J; Zhou Y; Sheng M; Wang T; Gao F
    Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):526-8. PubMed ID: 12667316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A promising strategy for overcoming MDR in tumor by magnetic iron oxide nanoparticles co-loaded with daunorubicin and 5-bromotetrandrin.
    Cheng J; Wang J; Chen B; Xia G; Cai X; Liu R; Ren Y; Bao W; Wang X
    Int J Nanomedicine; 2011; 6():2123-31. PubMed ID: 22114476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of tetrandrine on SORCIN gene expression in K562/A02 cell line].
    Li J; Chen BA; Zhu MS; Gao F; Ding JH; Gao C; Sun YY; Cheng J; Wang J; Zhao G; Song HH; Ma Y; Bao W; Sun XC; Cheng HY; Xu WL; Shen HL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):65-9. PubMed ID: 18315902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells.
    Liu ZL; Hirano T; Tanaka S; Onda K; Oka K
    J Pharm Pharmacol; 2003 Nov; 55(11):1531-7. PubMed ID: 14713364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of multidrug resistance in xenograft nude-mice by magnetic Fe(3)O(4) nanoparticles combined with daunorubicin and 5-bromotetrandrine.
    Wu YN; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):60-4. PubMed ID: 19236748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Embelin Reverses the Multi-drug Resistance of K562/D to Daunorubicin Independently of P-gp and MDR1 mRNA].
    Jiang HN; Liu ZG; Hu R
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1342-1349. PubMed ID: 29070105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daunorubicin-loaded magnetic nanoparticles of Fe(3)O(4) greatly enhance the responses of multidrug-resistant K562 leukemic cells in a nude mouse xenograft model to chemotherapy.
    Lai BB; Chen BA; Cheng J; Gao F; Xu WL; Ding JH; Gao C; Sun XC; Li GH; Chen WJ; Liu LJ; Li XM; Wang XM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):345-51. PubMed ID: 19379564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of
    Wang J; Wang ZJ; Li ZX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):45-51. PubMed ID: 38387898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.
    Chen BA; Shan XY; Chen J; Xia GH; Xu WL; Schmit M
    Chin J Cancer; 2010 Jun; 29(6):591-5. PubMed ID: 20507731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and characterization of tumor-targeted copolymer nanocarrier modified by transferrin.
    Liu R; Wang Y; Li X; Bao W; Xia G; Chen W; Cheng J; Xu Y; Guo L; Chen B
    Drug Des Devel Ther; 2015; 9():2705-19. PubMed ID: 26045659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.